Details for 2020820054

Up to date per 01.04.2026

Actions

Title / Product Name

ANFÄNGLICHE DREIFACHKOMBINATIONSTHERAPIE MIT MACITENTAN, TADALAFIL UND SELEXIPAG ZUR BEHANDLUNG VON PULMONALER ARTERIELLER HYPERTENSION

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2020820054

EP Publication Number

4065119

E-Number

1719661

Language

PCT Number

EP20083593

Publication Date

05.10.2022 A

04.09.2024 B1

Registration Date

04.09.2024

AT Publication Date

15.09.2024

Application Date

27.11.2020

Registration Number

Priorities

29.11.2019

201962941910 P

12.05.2020

202063023452 P

09.09.2020

202063076149 P

IPC

A61K 31/4965 20060101AFI20210604BHEP

Maximum Duration of Protection

27.11.2040

Owner

Actelion Pharmaceuticals LtdGewerbestrasse 16 4123 AllschwilCH

Representative

No representatives present

Inventor

MARESTA, AlessandroGewerbestrasse 16 4123 AllschwilCH

PERCHENET, LoïcActelion Pharmaceuticals Ltd Gewerbestrasse 16 4123 AllschwilCH